Antidepressive treatment during pregnancy can affect newborn brain activity

Fetal exposure to commonly used SRI drugs may affect brain activity in newborns, new research shows. The researchers suggest that the effects of drugs on fetal brain function should be assessed more carefully. Furthermore, indications for preventive medication should be critically evaluated, and non-pharmacological interventions should be the first-line treatment for depression and anxiety during pregnancy.